California Public Employees Retirement System Has $82.76 Million Holdings in MetLife, Inc. (NYSE:MET)

California Public Employees Retirement System decreased its position in MetLife, Inc. (NYSE:MET - Free Report) by 6.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,010,794 shares of the financial services provider's stock after selling 66,087 shares during the period. California Public Employees Retirement System owned approximately 0.15% of MetLife worth $82,764,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in MET. RWA Wealth Partners LLC lifted its holdings in MetLife by 6.6% in the fourth quarter. RWA Wealth Partners LLC now owns 7,225 shares of the financial services provider's stock worth $592,000 after purchasing an additional 446 shares during the period. Schroder Investment Management Group lifted its stake in shares of MetLife by 4.6% in the 4th quarter. Schroder Investment Management Group now owns 328,964 shares of the financial services provider's stock worth $26,814,000 after acquiring an additional 14,582 shares during the period. MV Capital Management Inc. boosted its holdings in shares of MetLife by 27.8% in the fourth quarter. MV Capital Management Inc. now owns 4,028 shares of the financial services provider's stock valued at $330,000 after acquiring an additional 877 shares in the last quarter. Allianz SE bought a new stake in MetLife during the fourth quarter worth approximately $8,882,000. Finally, Intrust Bank NA lifted its position in MetLife by 2.1% in the fourth quarter. Intrust Bank NA now owns 34,058 shares of the financial services provider's stock worth $2,789,000 after purchasing an additional 710 shares during the period. Institutional investors and hedge funds own 94.99% of the company's stock.

Remove Ads

MetLife Stock Up 1.8 %

NYSE:MET traded up $1.45 during mid-day trading on Wednesday, reaching $82.61. The stock had a trading volume of 3,205,119 shares, compared to its average volume of 3,285,018. The stock has a market cap of $56.28 billion, a P/E ratio of 13.84, a PEG ratio of 0.65 and a beta of 1.04. The business's 50 day moving average is $82.98 and its 200 day moving average is $83.01. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a fifty-two week low of $67.30 and a fifty-two week high of $89.05.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were paid a dividend of $0.545 per share. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. MetLife's dividend payout ratio (DPR) is presently 36.52%.

Analyst Ratings Changes

A number of research firms have recently commented on MET. Barclays dropped their price objective on MetLife from $96.00 to $95.00 and set an "overweight" rating on the stock in a research note on Friday, February 7th. UBS Group raised their price objective on shares of MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research report on Wednesday. BMO Capital Markets began coverage on shares of MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 target price on the stock. JPMorgan Chase & Co. decreased their price target on shares of MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday. Finally, Keefe, Bruyette & Woods dropped their price target on MetLife from $100.00 to $98.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 12th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and a consensus price target of $94.85.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.